Metabolomic biomarker differences of sarcopenia in older patients with sepsis - Top-Institutions - MDSpire

Metabolomic biomarker differences of sarcopenia in older patients with sepsis

  • By

  • Yiyang Liu

  • Tianren He

  • Siyu Chen

  • Ziyi Li

  • Xue Mei

  • Xinhua He

  • Na Shang

  • April 30, 2026

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Geriatrics
    • Critical Care Medicine
    • Metabolomics

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Geriatrics
    • Critical Care
    • Systems Biology

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Critical Care Medicine
    • Geriatrics
    • Metabolomics

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Geriatrics
    • Critical Care
    • Metabolomics

  • #5

    University of Pittsburgh Medical Center (UPMC)
    University of Pittsburgh Medical Center (UPMC)

    Pittsburgh, PA

    Key Differentiators

    • Critical Care Medicine
    • Geriatrics
    • Metabolomics

Original Source(s)

Metabolomic biomarker differences of sarcopenia in older patients with sepsis

  • by Yiyang Liu, Tianren He, Siyu Chen, Ziyi Li, Xue Mei, Xinhua He, Na Shang

  • April 30, 2026

Related Content

Evaluation of ambulance blood cultures in patients with suspected sepsis. A rural prospective cohort study

Neutrophil immunometabolism in ACLF and sepsis: mechanisms, dysfunction, and therapeutic opportunities

Clinical impact of EUCAST rapid antimicrobial susceptibility testing on empirical therapy in bloodstream infections: a real-world observational study